{
  "chapter": "NACO",
  "questions": [
    {
      "q_no": 1,
      "question": "Identify the organization that has the given emblem:",
      "options": {
        "A": "National Vector Borne Disease Control Programme",
        "B": "National Leprosy Eradication Programme",
        "C": "Integrated Child Development Services",
        "D": "National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases, and Stroke"
      },
      "correct_answer": "C",
      "explanation": "",
      "image": "https://raw.githubusercontent.com/tk22kalal2/mcqimage/main/mpsm/q1_img1_3cb60662.jpeg",
      "explanation_image": "https://raw.githubusercontent.com/tk22kalal2/mcqimage/main/mpsm/exp1_img1_799d9b9b.jpeg",
      "chapter_heading": "NACO"
    },
    {
      "q_no": 2,
      "question": "The following drug packet is used in:363",
      "options": {
        "A": "TB",
        "B": "Leprosy",
        "C": "Vaginal discharge",
        "D": "GonorrheaVA"
      },
      "correct_answer": "B",
      "explanation": "The given image shows the adult blister packet used in the treatment of leprosy.",
      "image": "https://raw.githubusercontent.com/tk22kalal2/mcqimage/main/mpsm/q2_img1_6646f293.jpeg",
      "explanation_image": null,
      "chapter_heading": "NACO"
    },
    {
      "q_no": 3,
      "question": "The Sparsh campaign was launched to spread awareness about which of the followingdiseases?",
      "options": {
        "A": "HIV",
        "B": "Immunization",
        "C": "Leprosy",
        "D": "TB"
      },
      "correct_answer": "C",
      "explanation": "Sparsh Leprosy Awareness Campaign (SLAC) was introduced in 2017 on the occasion of theanti-leprosy day (observed on the last Sunday of January) to promote awareness about variousaspects of leprosy.373Sapna refers to a local school-going girl who will help to spread awareness in the community.The other developments under NLEP are:••Mycobacterium Indicus Prani (MiP) vaccine for multibacillary leprosy patients and their contacts(it is in a project mode).Nikusth: A web-based system for the data management of leprosy cases.Note: Meena is a nine-year-old girl, who is the symbol of UNICEF's Girl Empowermentprogramme to impart important messages on gender, child rights, education, health anddevelopment in the South Asian region.The posters below depict the role play by Sapna:Aunty, have you taken Babļooto the doctor to show thislight-coloured patch onhis hand?Arrey Sapna.this is nothing! Kidskeep getting a hundred things nowand then it will go away in a daySapna, where are you taking me? You knowIam taking MOT forgo to the wedding because people will thinkthat I may spread theNo aunty! Please don't ignore this Light-coloured skin patchwithout sensation can be a symptom of leprosy, Getablchecked immediately by a doctor. If treatment is started earlywith MOT, it will prevent disability.or two.Amey Aunty You don'tpeople, Leprosy does npedroughtouchCome join the wedding5EARLY DIAGNOSIS WILL ENSURE COMPLETE CUREOF LEPROSY AND PREVENT DISABILITYEarly diagnons, appropriate treatment and completion of the full core of· treatment will prevent disability due to lepotayLEPROSY DOES NOT SPREAD THROUGH TOUCHCatching hand or playing together or working in the same oflow",
      "image": null,
      "explanation_image": "https://raw.githubusercontent.com/tk22kalal2/mcqimage/main/mpsm/exp3_img1_b8a0bb3a.jpeg",
      "chapter_heading": "NACO"
    },
    {
      "q_no": 4,
      "question": "A patient with leprosy comes to the PHC following a pinprick to his foot. He noticed it onlyafter seeing bloodstains on the floor and complains of loss of sensation in his foot. Afteraddressing the issue, the patient is referred to another centre. Where has he been referred toand why?",
      "options": {
        "A": "For secondary prevention to a district hospital.",
        "B": "For tertiary prevention to a district hospital.",
        "C": "For secondary prevention to a district nucleus.364",
        "D": "For tertiary prevention to a district nucleus."
      },
      "correct_answer": "D",
      "explanation": "The given clinical scenario of a patient with leprosy having neuropathy needs Micro CellularRubber (MCR) footwear, which is a form of tertiary prevention. He is to be referred to adistrict nucleus which supplies MCR footwear to patients.374System of levels of Implementation &Referral in NLEPSubcentre• Gives advice for self-care and monitoringRefers lepra reactions anddisability casesPHC• Manages lepra reactions if possibleComplicatedlepra reactions &ulcersPatients whorequire footwearDistrict HospitalsManage complicatedulcers and lepra reactionsDistrict NucleusSupplies footwear topatientsManages lepra reactionsDifficult ulcercasesDifficult ulcercasesReconstructive Surgery CentresReconstructive surgery & followupSupply of footwear to the District NucleusMARROW",
      "image": null,
      "explanation_image": "https://raw.githubusercontent.com/tk22kalal2/mcqimage/main/mpsm/exp4_img1_b37bf96d.jpeg",
      "chapter_heading": "NACO"
    },
    {
      "q_no": 5,
      "question": "A patient with leprosy, who has completed a course of multi-drug therapy, presents withcomplaints of developing painful, tender, and raised lesions on his forehead recently asshown in the image below. What is the first-line treatment for him?",
      "options": {
        "A": "Restart multi drug therapy and start thalidomide",
        "B": "Restart multi drug therapy and start prednisolone",
        "C": "Start on clofazimine only",
        "D": "Start on prednisolone only& DAILY ROUNDS"
      },
      "correct_answer": "D",
      "explanation": "The presence of new erythematous and tender subcutaneous nodules in a patient with leprosyindicates that he has developed type II lepra reaction. It is also known as Erythema NodosumLeprosum (ENL) and the first line of treatment is prednisolone.Multi-drug therapy (MDT) should not be restarted in patients who develop lepra reactions afterthe completion of treatment.Prednisolone is started at a dose of 40 mg per day and gradually tapered by 5 mg every 2 weeks.'Prednisolone card' is given when treatment is started. If the patient becomes steroid-dependent,then clofazimine is added.The key targets of the Global Leprosy Strategy 2021-2023 announced by WHO (Acceleratingtowards a leprosy-free world) are:• 120 countries reporting zero new autochthonous cases.• 70% reduction in the annual number of new cases detected.• 90% reduction in rate per million population of new cases with Grade 2 disability.• 90% reduction in rate per million children of new child cases with leprosy.The current goal is the elimination of leprosy.",
      "image": "https://raw.githubusercontent.com/tk22kalal2/mcqimage/main/mpsm/q5_img1_a75b44c5.jpeg",
      "explanation_image": null,
      "chapter_heading": "NACO"
    },
    {
      "q_no": 6,
      "question": "ABSULS, which is an ASHA-based surveillance project, has been initiated for which of thefollowing diseases?",
      "options": {
        "A": "Leishmaniasis",
        "B": "Diarrhoeal diseases",
        "C": "Leprosy",
        "D": "Sexually Transmitted Diseases (STDs)"
      },
      "correct_answer": "C",
      "explanation": "ABSULS which stands for Asha Based Surveillance for Leprosy Suspects has been initiated toprioritize leprosy case detection by ASHAS.375",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "NACO"
    },
    {
      "q_no": 7,
      "question": "365The treatment of paucibacillary leprosy consists of MDT (which comprises rifampicin,dapsone, and clofazimine). The latest recommended regimen is:",
      "options": {
        "A": "2 drug therapy for 6 months",
        "B": "3 drug therapy for 12 months",
        "C": "2 drug therapy for 12 months",
        "D": "3 drug therapy for 6 months"
      },
      "correct_answer": "D",
      "explanation": "The latest recommendation is 3 drug therapy for 6 months to treat paucibacillary (PB) leprosy byWHO. The regimen consists of rifampicin, dapsone, and clofazimine.Meanwhile, multibacillary (MB) leprosy is treated using the same 3 drugs for a duration of 12months. While the NLEP guidelines earlier mentioned a 2-drug MDT for PB leprosy, the NationalStrategic Plan and Roadmap for Leprosy (2023-2027) now recommends a uniform MDT of 3drugs for both PB and MB leprosy.Note: The central government has approved a new treatment regimen for paucibacillary (PB)leprosy. The Ministry of Health and Family Welfare has introduced a 3-drug regimen for PBleprosy instead of a 2-drug regimen. This revised drug regimen will be applicable in India fromApril 1, 2025.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "NACO"
    },
    {
      "q_no": 8,
      "question": "A District Leprosy Officer is preparing the annual report as per NLEP 2020. Which of thefollowing parameters would he not consider as an essential indicator?",
      "options": {
        "A": "Treatment Completion Rate (TCR)",
        "B": "Prevalence rate (PR)",
        "C": "Rate of new cases with Grade II disabilities per 10 lakh population per year",
        "D": "Proportion of new cases correctly diagnosed"
      },
      "correct_answer": "D",
      "explanation": "The proportion of new cases correctly diagnosed is not included under essential indicators. It is apart of the quality of service indicators as per NLEP 2020.The essential indicators include:• Annual new case detection rate (ANCDR) per 1 lakh population.• Rate of new cases with grade II disabilities (G2D) per 10 lakh population per year.• Treatment completion rate (TCR) as a proxy to cure rate.• Prevalence rate (PR).Additional epidemiological indicators include:• Proportion of Grade II disabilities among new cases.•Proportion of females among new cases..Proportion of multibacillary (MB) among new cases.•• Proportion of child (0- 14 years) among new cases.• Child rate per 100,000 population.•Scheduled Caste New Case Detection Rate.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "NACO"
    },
    {
      "q_no": 9,
      "question": "As per NLEP 2020, which of the following is not a quality of service indicator?",
      "options": {
        "A": "Patient month blister calendar pack stock",
        "B": "Proportion of grade II disabilities among new cases.",
        "C": "Number of relapses reported",
        "D": "Proportion of cases who developed new or additional disability after starting MDT"
      },
      "correct_answer": "B",
      "explanation": "Proportion of grade II disabilities among new cases is not a quality of service indicator. It is anadditional epidemiological indicator as per NLEP 2020.The quality of service indicators are:• Patient month blister calendar pack stock.•Absolute number of patients made released from treatment (RFT).376• Number of relapse reported.•.•Proportion of cases who developed new or additional disability after starting MDT.• Proportion of treatment defaulters.• Proportion of new cases correctly diagnosed.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "NACO"
    },
    {
      "q_no": 10,
      "question": "You are part of a rural health camp organized under Project Axshya. Which of the followingdiseases does it aim to control?",
      "options": {
        "A": "Diabetes",
        "B": "Kala azar",
        "C": "Tuberculosis",
        "D": "Zika Virus disease366"
      },
      "correct_answer": "C",
      "explanation": "Project Axshya was launched in 2010 to control TB. Axshya means free from TB which is theultimate goal of the project and the National TB Elimination Programme.Project Axshya is being implemented by the International Union Against Tuberculosis and LungDisease (known simply as The Union). The project works to improve access to quality TB care andcontrol through a partnership between the government and civil society.The guiding principles of project Axshya are:•Universal access to quality TB services•Community participation in TB care and control• Sustainable interventions and equitable distribution of project benefits with social and gendersensitivity",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "NACO"
    },
    {
      "q_no": 11,
      "question": "You are working as a medical officer in a PHC where you diagnose a patient with TB. Withinhow many days do you have to report it to the District Health Officer?",
      "options": {
        "A": "7 days",
        "B": "15 days",
        "C": "30 days",
        "D": "21 days"
      },
      "correct_answer": "",
      "explanation": "The guidelines for TB notification under the RNTCP is within 30 days (a month) of receiving anew case. The notification must be done to the District Health Officer or the Chief Medical Officerof a District Hospital by the practitioner who diagnosed it.Note: RNTCP has now been renamed to National Tuberculosis Elimination Program (NTEP).",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "NACO"
    },
    {
      "q_no": 12,
      "question": "Which of the following is true about the Revised National Tuberculosis Control Programme?",
      "options": {
        "A": "Follow-up sputum smear examination at the end of intensive phase only",
        "B": "Directly Observed Treatment Short course strategy is applied",
        "C": "Treatment is only given to smear positive cases",
        "D": "MDR TB is resistance to either rifampicin or isoniazid"
      },
      "correct_answer": "B",
      "explanation": "DOTS stands for Directly Observed Treatment Short-course and is given by peripheral andvoluntary health workers.Recent updates in RNTCP:• Active case finding for TB has been started.• Follow up:.• On treatment: monthly follow up.••After treatment: Follow up at 6, 12, 18 and 24 months.• A sputum smear examination must be done at the end of intensive phase (IP) and at the end oftreatment.377",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "NACO"
    },
    {
      "q_no": 13,
      "question": "A patient presents with fever, productive cough, and weight loss. He gives a history of nothaving completed treatment for tuberculosis thrice in the past. Extensively drug-resistant TBis suspected. How is this entity defined?",
      "options": {
        "A": "Resistance to INH + Amikacin + Ofloxacin + Ethambutol",
        "B": "Resistance to INH + Rifampicin + Amikacin",
        "C": "Resistance to Rifampicin + Amikacin+ Ofloxacin",
        "D": "Resistance to INH + Rifampicin + Ofloxacin + Linezolid"
      },
      "correct_answer": "D",
      "explanation": "XDR-TB (extensively drug-resistant TB) is defined as multi-drug resistant TB (resistant torifampicin and isoniazid) which is also resistant to one fluoroquinolone (eg. ofloxacin)AND resistant to atleast one additional group A drug (as of 2021, theseare bedaquiline and linezolid)It is usually seen in patients who have previously received treatment for TB and have either failedto complete treatment or relapsed.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "NACO"
    },
    {
      "q_no": 14,
      "question": "A patient on HAART presents with complaints of fever and expectorant cough for two weeks.What is the investigation to be ordered first?",
      "options": {
        "A": "Sputum microscopy",
        "B": "Interferon Gamma Release Assay",
        "C": "CB- NAAT367",
        "D": "Sputum microscopy and Chest X-ray"
      },
      "correct_answer": "",
      "explanation": "An HIV patient suspected to have TB is directly investigated by CB-NAAT (Cartridge BasedNucleic Acid Amplification Test).TB is a very serious infection in the immunocompromised and can lead to its most severe form asmiliary TB and cause death. Since TB in HIV does not have its typical presentation, earlysuspicion and advanced diagnosis is the key to preventing mortality.Diagnostic algorithm for TB:PLHIVDiagnostic algorithm for TB in HIVSmear examinationPresumptiveTB patientCXRSmear +veSmear +veCXRsuggestsTBCXRdoesn'tsuggest TBSmearCXRsuggestsTO-+-veBoth smearandCXR -veClinicalsuspicionhighIf high MDAsettings.PMDTcriteriaCB-NAATMTBdetectedMTB notdetectedRifsensitiveMicrobiologicallyconfirmed TBRifindeterminateRepeatCB-NAATon 2ndsampleConsideralternatediagnosisand refer tospecialistClinicallydiagnosedAlternatediagnosisRifresistantRefer tomanagementforresistanceIf indeterminate, collect freshsample for liquid cultureOMARROW",
      "image": null,
      "explanation_image": "https://raw.githubusercontent.com/tk22kalal2/mcqimage/main/mpsm/exp14_img1_7f25ab50.jpeg",
      "chapter_heading": "NACO"
    },
    {
      "q_no": 15,
      "question": "Which of the following statements is false under the National Tuberculosis EliminationProgramme?",
      "options": {
        "A": "Continuation phase for new sputum smear positive: HRE for 16 weeks",
        "B": "Intensive phase for sputum smear positive after loss to follow up: HRZE for 8 weeks",
        "C": "Continuation phase for sputum smear positive recurrent case: HRE for 16 weeks",
        "D": "Intensive phase for sputum smear positive after failure to treatment: HRZES for 12 weeks"
      },
      "correct_answer": "D",
      "explanation": "Under National Tuberculosis Elimination Programme (NTEP) guidelines Initiation phase (IP) forboth new and previously treated cases which are H and R sensitive is HRZE for 8 weeks.378",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "NACO"
    },
    {
      "q_no": 16,
      "question": "Which of the following is the most peripheral centre under the Revised National TuberculosisControl Programme organization structure?",
      "options": {
        "A": "District TB centre",
        "B": "Intermediate Reference Laboratory",
        "C": "Tuberculosis Unit",
        "D": "Designated Microscopy Centre"
      },
      "correct_answer": "D",
      "explanation": "Among the options given, Designated Microscopy Centre is the most peripheral centre.Structure of the RNTCP(Revised National Tuberculosis Control Programme)Central TB divisionState TB cellDistrict TB centerTuberculosis unitDesignated MicroscopycenterPeripheral healthinstitution",
      "image": null,
      "explanation_image": "https://raw.githubusercontent.com/tk22kalal2/mcqimage/main/mpsm/exp16_img1_06e6a6c4.jpeg",
      "chapter_heading": "NACO"
    },
    {
      "q_no": 17,
      "question": "Which is the new online software launched under the national tuberculosis eliminationprogram (NTEP) by the government to monitor TB patients?",
      "options": {
        "A": "NIKSHAY",
        "B": "NISCHAY",
        "C": "E-DOTS",
        "D": "NIKUSTH"
      },
      "correct_answer": "A",
      "explanation": "Nikshay is the new online software launched under the national tuberculosis elimination programfor monitoring TB patients.Nikusth is the new online software for monitoring leprosy patients.Nischay is a pregnancy test kit.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "NACO"
    },
    {
      "q_no": 18,
      "question": "Choose the false statement regarding the initiatives and strategies for tuberculosis.",
      "options": {
        "A": "The Stop TB strategy was announced by the World Health Organisation368",
        "B": "The STOP TB strategy has a target of ending TB by achieving an incidence rate of &lt;10 peopleper 10,000 population per year",
        "C": "The \"Practical approach to lung health\" was launched by the WHO for syndromic managmentof patients with respiratory symptoms",
        "D": "The End TB strategy is a 20 year programme"
      },
      "correct_answer": "B",
      "explanation": "The Stop TB strategy was announced by World Health Organisation to reduce the global burdenof TB by 2015 (and not ending TB).The End TB strategy is a 20-year programme with tagline \"A world free of TB - Zero TB deaths,Zero TB disease, and Zero TB suffering\". It aims to:⚫end TB by achieving an incidence rate of &lt;10 people/1 lakh population per year by 2035.•reduce TB deaths by 95% and cut new cases by 90% by 2035.The \"Practical approach to lung health initiative\" was launched by the WHO as a syndromicapproach to the management of patients who attend primary health care services for respiratorysymptoms.Ending the TB epidemic is also one of the targets of the Sustainable Development Goals (SDG)specifically under Goal 3 (to \"ensure healthy lives and promote well-being for all at all ages\").379WHO defines that \"Tuberculosis control\" would be achieved when the prevalence of the naturalorder of infection in the age group of 0-14 years is of the order of 1% (40% in India currently).Vision of End TB: A world free of TB- zero deaths, diseaseand suffering due to TBGoal: End the global TB epidemicIndicatorsTargetsSDG 2030End TB 2035Reduction in no. of TB deaths compared with 201590%95%Reduction in TB incidence rate compared with 201580% (<20/1,00,090% (<10/1,00,000)00)TB-affected families facing catastrophic costs due to TB0%0%",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "NACO"
    },
    {
      "q_no": 19,
      "question": "Which of the following group of individuals would you not target under the programmerepresented by the logo shown below?",
      "options": {
        "A": "Sex workers",
        "B": "Migrants",
        "C": "Transgenders",
        "D": "Industrial workers"
      },
      "correct_answer": "D",
      "explanation": "The red ribbon shown is a part of the logo of the National AIDS Control Organization (NACO)programme. Industrial workers are not included in the target population under NACO.Target interventions for the control of AIDS transmission are done for:•High-risk groups like sex workers• Men who have sex with men•Transgender•Injecting drug users●Bridge population like migrants and long-distance truckersThe services offered through targeted interventions include detection and treatment for sexuallytransmitted diseases and condom distribution.The logo of NACO:380NACO",
      "image": "https://raw.githubusercontent.com/tk22kalal2/mcqimage/main/mpsm/q19_img1_654deeea.jpeg",
      "explanation_image": "https://raw.githubusercontent.com/tk22kalal2/mcqimage/main/mpsm/exp19_img1_cbb9b7f0.jpeg",
      "chapter_heading": "NACO"
    },
    {
      "q_no": 20,
      "question": "Which of the following statements is false regarding the target interventions under NationalAIDS Control Organisation?",
      "options": {
        "A": "Lubricants are given to homosexual men",
        "B": "Clean needles and syringes are given to injecting drug users",
        "C": "Condoms are not given to bridge population",
        "D": "Opioid substitution therapy is given to Injecting Drug Users369"
      },
      "correct_answer": "",
      "explanation": "Bridge populations are supplied with condoms under the NACO target interventions.Target interventions:General:• Detection and treatment for sexually transmitted diseases• Condom distributionFor injecting drug users:⚫ Distribution of clean needles and syringes.•• Abscess prevention and management.•Opioid substitution therapy.• Linkage with detoxification and rehabilitation services.For homosexual men and transgenders:•Provision of lubricants.•Provision of project-based clinics for sexually transmitted infections.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "NACO"
    },
    {
      "q_no": 21,
      "question": "A physician follows the two test protocol for the diagnosis of HIV in a patient. It consists of:",
      "options": {
        "A": "Western blot as the first test",
        "B": "Line immunoassay as the second test.",
        "C": "HIV ELISA as the second test",
        "D": "Western blot as the second test"
      },
      "correct_answer": "",
      "explanation": "The two test protocol for the diagnosis of HIV consists of ELISA as the second test. If the initialELISA is positive, a second ELISA is carried out. If the second ELISA is also positive, only thenthe case is reported to be positive.Investigations involved in HIV testing strategies:381• ELISA/ rapid tests..•⚫ Confirmatory tests with high specificity like western blot and line immunoassays are used inproblem cases eg: indeterminate/ discordant cases of rapid tests.In India, NACO provides western blot (WB) confirmatory testing only to resolve indeterminateresults on previous serological testing. It is not used for routine confirmation after a positiveresult on screening tests. Drawbacks of WB include low rates of detection during acuteHIV infection and misclassification of HIV-2 infection.Note: The western blot is used as a confirmatory test after 2 indeterminate primary tests (ELISA).It is essentially the third test used and does not fit into the two test protocol.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "NACO"
    },
    {
      "q_no": 22,
      "question": "As a medical officer involved in the sentinel surveillance for HIV under the National AIDSControl Programme, your duties include all of the following except:",
      "options": {
        "A": "Estimation of total infection in the community",
        "B": "Estimation of total cases in hospitals",
        "C": "Estimation of trend of disease",
        "D": "Classification of districts"
      },
      "correct_answer": "",
      "explanation": "As a medical officer involved in the sentinel surveillance, the estimation of total cases in hospitalsis not included in the sentinel surveillance for HIV under National AIDS Control Programme(NACO).The aims of the HIV sentinel surveillance include:• Determine the level of HIV infection in the community.• Understand the trends of HIV epidemic.• Understand the geographical spread of HIV infection and classify districts according toepidemiological and vulnerability criteria.These objectives are achieved by conducting annual cross-sectional surveys of the risk group inthe same geographical place.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "NACO"
    },
    {
      "q_no": 23,
      "question": "Which of the following is targetted by the establishment bearing the logo shown below:",
      "options": {
        "A": "Family planningsurakshaclinic370",
        "B": "Immunisation",
        "C": "Sexually Transmitted Diseases",
        "D": "Maternal and Child Health Services"
      },
      "correct_answer": "",
      "explanation": "The logo shown represents Suraksha Clinics which are established for the management of sexuallytransmitted diseases (STDs) where patients are given color-coded kits.",
      "image": "https://raw.githubusercontent.com/tk22kalal2/mcqimage/main/mpsm/q23_img1_47d5c77b.jpeg",
      "explanation_image": null,
      "chapter_heading": "NACO"
    },
    {
      "q_no": 24,
      "question": "Choose the wrong combination of the colour-coded STI kits among the given options.",
      "options": {
        "A": "Kit 6 yellow-",
        "B": "Kit 3 - white",
        "C": "Kit 4 - black",
        "D": "Kit 5 - red"
      },
      "correct_answer": "",
      "explanation": "Kit 4 is blue in colour and is used for genital ulcers. These kits are given at Suraksha clinics.382",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "NACO"
    }
  ]
}